免疫介导性再生障碍性贫血患者淋巴细胞的体细胞突变
该研究用2533基因定制panel对24例免疫介导性再生障碍性贫血(AA)患者的CD4+和CD8+ T细胞进行测序,并与20例健康对照及37例AA患者全外显子测序比较。体细胞突变在患者和健康对照中均常见,但富集于AA患者CD8+ T细胞,且突变负荷与CD8+ T细胞克隆性相关;携带STAT3突变的克隆具细胞毒性,经成功免疫抑制治疗后减弱。
要点
- AA患者CD8+ T细胞体细胞突变富集,多累及JAK-STAT和MAPK通路。
- 突变负荷与CD8+ T细胞克隆性(TCRβ测序评估)相关。
- STAT3突变克隆具细胞毒性,免疫抑制治疗后可减弱。
核心结论
- T细胞体细胞突变常见,与克隆性相关,并可改变T细胞表型,值得进一步研究其在AA发病中的作用。
研究设计与样本
- 用2533基因定制panel对24例AA患者CD4+和CD8+ T细胞测序,并与20例健康对照及37例AA患者全外显子测序比较。
- 对携带STAT3或其他突变的AA患者CD8+ T细胞进行单细胞测序。
主要发现
- 体细胞变异在患者和健康对照中均常见,但富集于AA患者CD8+ T细胞。
- AA患者CD8+ T细胞突变最常累积于JAK-STAT和MAPK通路。
- 突变负荷与CD8+ T细胞克隆性相关,克隆性由T细胞受体β测序评估。
- STAT3突变克隆具细胞毒性,与其他CD8+ T细胞明显不同,并经成功免疫抑制治疗减弱。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The prevalence and functional impact of somatic mutations in nonleukemic T cells is not well characterized, although clonal T-cell expansions are common. In immune-mediated aplastic anemia (AA), cytotoxic T-cell expansions are shown to participate in disease pathogenesis. We investigated the mutation profiles of T cells in AA by a custom panel of 2533 genes. We sequenced CD4+ and CD8+ T cells of 24 AA patients and compared the results to 20 healthy controls and whole-exome sequencing of 37 patients with AA. Somatic variants were common both in patients and healthy controls but enriched to AA patients' CD8+ T cells, which accumulated most mutations on JAK-STAT and MAPK pathways. Mutation burden was associated with CD8+ T-cell clonality, assessed by T-cell receptor beta sequencing. To understand the effect of mutations, we performed single-cell sequencing of AA patients carrying STAT3 or other mutations in CD8+ T cells. STAT3 mutated clone was cytotoxic, clearly distinguishable from other CD8+ T cells, and attenuated by successful immunosuppressive treatment. Our results suggest that somatic mutations in T cells are common, associate with clonality, and can alter T-cell phenotype, warranting further investigation of their role in the pathogenesis of AA.
引用
- Lundgren S, Keränen MAI, Kankainen M, et al. Somatic mutations in lymphocytes in patients with immune-mediated aplastic anemia. Leukemia. 2021. PMID: 33785863. doi:10.1038/s41375-021-01231-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。